Multiple Sclerosis Trial, Recruiting (NCT06441617)

Multiple Sclerosis Trial, Recruiting NCT06441617 Sponsor: Accelerated Cure Project for Multiple Sclerosis Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06441617 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have given your agreement to take part in the study
You currently live in the United States
You are 22 years old or older
A neurologist has confirmed that you have been diagnosed with multiple sclerosis (MS)
Your fatigue (tiredness related to MS) has been measured as being above a certain level on a standard questionnaire (confirm with trial site for the exact score required)
You are fluent in English
You are willing to use an online program on your own for 24 weeks and complete check-in surveys after it ends
You have access to the internet and email through a smartphone, computer, or tablet
You have not had an MS relapse or taken steroid treatment in the 4 weeks before filling out the screening questionnaire (based on your own report)
You have not started any new MS disease treatment in the 4 weeks before filling out the screening questionnaire (based on your own report)

Who may not be able to join:

You are unwilling or unable to give your agreement to take part
You do not agree to allow your anonymised data to be saved, used, and shared as part of the study
You are currently taking part in another clinical trial that involves a treatment or intervention

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 781-487-0008

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06441617

Sponsor: Accelerated Cure Project for Multiple Sclerosis

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 781-487-0008

More information: https://clinicaltrials.gov/study/NCT06441617

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have given your agreement to take part in the study
You currently live in the United States
You are 22 years old or older
A neurologist has confirmed that you have been diagnosed with multiple sclerosis (MS)
Your fatigue (tiredness related to MS) has been measured as being above a certain level on a standard questionnaire (confirm with trial site for the exact score required)
You are fluent in English
You are willing to use an online program on your own for 24 weeks and complete check-in surveys after it ends
You have access to the internet and email through a smartphone, computer, or tablet
You have not had an MS relapse or taken steroid treatment in the 4 weeks before filling out the screening questionnaire (based on your own report)
You have not started any new MS disease treatment in the 4 weeks before filling out the screening questionnaire (based on your own report)

Who may not be able to join:

You are unwilling or unable to give your agreement to take part
You do not agree to allow your anonymised data to be saved, used, and shared as part of the study
You are currently taking part in another clinical trial that involves a treatment or intervention

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Accelerated Cure Project for Multiple Sclerosis

Registry

ClinicalTrials.gov

Start date

5 December 2024

Est. completion

15 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Chalder Fatigue Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov